Genetic Testing for Malignant Hyperthermia Susceptibility—Threading the Needle in the Haystack
Genes · 2025
DOI: 10.3390/genes16111281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2025. Verfasst von Anjan K Saha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Malignant Hyperthermia, Genetic Testing, Genetic Predisposition to Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder triggered by volatile anesthetics and succinylcholine, most often linked to pathogenic variants in RYR1, CACNA1S, and STAC3. The advent of next-generation sequencing (NGS) has transformed MH diagnostics, offering new opportunities for perioperative risk assessment as caffeine–halothane contracture testing declines. However, challenges remain, including incomplete penetrance, variable pathogenicity of variants, limited access to functional confirmatory testing, and cost. Genetic testing also raises important questions. What is the clinical utility of finding a variant of unknown significance? What are the broader implications of MH susceptibility beyond the operating room? Emerging evidence connects MH susceptibility loci to exertional heat illness (EHI), exertional rhabdomyolysis (ERM), and heat-related mortality, highlighting the need for a broader framework for genetic risk assessment. This review synthesizes historical advances, current consensus, and future directions concerning MH to guide anesthesiologists and perioperative clinicians in leveraging molecular diagnostics for personalized care and improved patient safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY 10032, USA.
ORCID-Profile: Anjan K Saha, Teeda Pinyavat
Förderung
- NIGMS NIH HHS
Zitieren
APA
Saha, A. K., & Pinyavat, T. (2025). Genetic Testing for Malignant Hyperthermia Susceptibility—Threading the Needle in the Haystack. Genes. https://doi.org/10.3390/genes16111281
Vancouver
Saha AK, Pinyavat T. Genetic Testing for Malignant Hyperthermia Susceptibility—Threading the Needle in the Haystack. Genes. 2025. doi:10.3390/genes16111281
BibTeX
@article{Saha2025,
author = {Saha, Anjan K and Pinyavat, Teeda},
title = {Genetic Testing for Malignant Hyperthermia Susceptibility—Threading the Needle in the Haystack},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16111281}
}
EUVIMED